List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
> 3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals |
Others observations: Age restriction > 3 years old. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
> 3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals |
Others observations: Age restriction > 3 years old. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
> 3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals |
Others observations: Age restriction > 3 years old. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
> 3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals |
Others observations: Age restriction > 3 years old. |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |